Martí Colom‐Cadena

Changes in Synaptic Proteins Precede Neurodegeneration Markers in Preclinical Alzheimer's Disease Cerebrospinal Fluid

Alberto Lleó, Raúl Núñez‐Llaves, Daniel Alcolea et al. · Molecular & Cellular Proteomics · 2019 · 242 citations · Full text

Synaptic oligomeric tau in Alzheimer’s disease — A potential culprit in the spread of tau pathology through the brain

Martí Colom‐Cadena, C. T. M. Davies, Sònia Sirisi et al. · Neuron · 2023 · 182 citations · Full text

Confluence of α-Synuclein, Tau, and β-Amyloid Pathologies in Dementia With Lewy Bodies

Martí Colom‐Cadena, Ellen Gelpí, Sara Charif et al. · Journal of Neuropathology & Experimental Neurology · 2013 · 167 citations · Full text

Pathology, Neurochemical Biomarkers, Protein Aggregates +21

Amyloid Beta and Tau Cooperate to Cause Reversible Behavioral and Transcriptional Deficits in a Model of Alzheimer’s Disease

Eleanor K. Pickett, Abigail G. Herrmann, Jamie McQueen et al. · Cell Reports · 2019 · 166 citations · Full text

PrP is a central player in toxicity mediated by soluble aggregates of neurodegeneration-causing proteins

Grant T. Corbett, Zemin Wang, Wei Hong et al. · Acta Neuropathologica · 2019 · 158 citations · Full text